ScripModerna Could Have Advantage Over Pfizer’s Cold Chain Moderna, Inc. has provided details about how its COVID-19 vaccine candidate mRNA-1273 will reach patients if and when it is approved, with cold
In VivoIN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over